Repligen (United States)
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Repligen (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
55%
Total
Publications
283
Total Open
Publications
155
Total
Citations
8.1K
Open Access
Percentage
55%
Total
Publications
283
Total Open
Publications
155
Total
Citations
8.1K
Breakdown
Publisher Open
19%
Both
20%
Other Platform Open
14%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
38
Hybrid 21%
22
No Guarantees 44%
47
Other Platform Open
Domain 65%
62
Institution 40%
38
Preprint 21%
20
Other Internet 14%
13
Public 5%
5
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 64 |
doaj.org OAI-PMH Repository | Institution | 25 |
bioRxiv | Preprint | 14 |
DOI | Other Internet | 11 |
medRxiv | Preprint | 5 |
Figshare | Public | 5 |
California Digital Library | Institution | 5 |
Unknown Repository | Other Internet | 2 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
Office of Scientific and Technical Information | Institution | 2 |